Journal
CELL RESEARCH
Volume 31, Issue 10, Pages 1039-1040Publisher
SPRINGERNATURE
DOI: 10.1038/s41422-021-00538-1
Keywords
-
Categories
Ask authors/readers for more resources
Maraviroc, an FDA-approved therapy, may be a potentially viable treatment option for patients diagnosed with glioblastoma harboring a high amount of pericyte support cells.
Maraviroc, an FDA-approved therapy, provides a potentially viable treatment option for those diagnosed with glioblastoma harboring a high amount of pericyte support cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available